Redcare Pharmacy NV (SHPPF)
USD 135.79
(0.0%)
USD 135.79
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 469.83 Million EUR | 25.34% |
| 2022 | 374.84 Million EUR | 1.95% |
| 2021 | 367.66 Million EUR | 228.94% |
| 2020 | 111.77 Million EUR | -42.74% |
| 2019 | 195.21 Million EUR | 43.63% |
| 2018 | 135.91 Million EUR | 130.98% |
| 2017 | 58.84 Million EUR | 117.08% |
| 2016 | 27.1 Million EUR | -32.76% |
| 2015 | 40.31 Million EUR | 326.46% |
| 2014 | 9.45 Million EUR | 23.71% |
| 2013 | 7.64 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 485.63 Million EUR | 3.43% |
| 2024 Q1 | 469.53 Million EUR | -0.06% |
| 2023 Q2 | 482.08 Million EUR | 16.82% |
| 2023 Q3 | 467.15 Million EUR | -3.1% |
| 2023 FY | 469.83 Million EUR | 25.34% |
| 2023 Q1 | 412.66 Million EUR | 10.09% |
| 2023 Q4 | 469.83 Million EUR | 0.57% |
| 2022 Q1 | 377.78 Million EUR | 2.75% |
| 2022 Q3 | 407.84 Million EUR | -0.74% |
| 2022 FY | 374.84 Million EUR | 1.95% |
| 2022 Q2 | 410.88 Million EUR | 8.76% |
| 2022 Q4 | 374.84 Million EUR | -8.09% |
| 2021 Q3 | 357.02 Million EUR | 1.26% |
| 2021 Q1 | 363.11 Million EUR | 224.87% |
| 2021 FY | 367.66 Million EUR | 228.94% |
| 2021 Q4 | 367.66 Million EUR | 2.98% |
| 2021 Q2 | 352.59 Million EUR | -2.9% |
| 2020 Q2 | 245.55 Million EUR | 2.09% |
| 2020 Q1 | 240.52 Million EUR | 23.21% |
| 2020 FY | 111.77 Million EUR | -42.74% |
| 2020 Q4 | 111.77 Million EUR | -55.16% |
| 2020 Q3 | 249.26 Million EUR | 1.51% |
| 2019 Q2 | 209.97 Million EUR | 36.35% |
| 2019 FY | 195.21 Million EUR | 43.63% |
| 2019 Q4 | 195.21 Million EUR | -8.33% |
| 2019 Q3 | 212.96 Million EUR | 1.42% |
| 2019 Q1 | 154 Million EUR | 13.31% |
| 2018 Q4 | 135.91 Million EUR | -2.75% |
| 2018 FY | 135.91 Million EUR | 130.98% |
| 2018 Q1 | 66.29 Million EUR | 12.66% |
| 2018 Q2 | 130.49 Million EUR | 96.85% |
| 2018 Q3 | 139.75 Million EUR | 7.09% |
| 2017 Q3 | 43.95 Million EUR | 51.74% |
| 2017 FY | 58.84 Million EUR | 117.08% |
| 2017 Q4 | 58.84 Million EUR | 33.87% |
| 2017 Q1 | 34.28 Million EUR | 26.5% |
| 2017 Q2 | 28.96 Million EUR | -15.52% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 43.3 Million EUR | 0.0% |
| 2016 Q4 | 27.1 Million EUR | -47.26% |
| 2016 Q3 | 51.4 Million EUR | 18.7% |
| 2016 FY | 27.1 Million EUR | -32.76% |
| 2015 Q4 | 40.31 Million EUR | 0.0% |
| 2015 FY | 40.31 Million EUR | 326.46% |
| 2015 Q1 | - EUR | 0.0% |
| 2014 FY | 9.45 Million EUR | 23.71% |
| 2013 FY | 7.64 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3.15 Million USD | -14799.709% |
| Allstar Health Brands, Inc. | 9.3 Million USD | -4949.993% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 52.97 Million USD | -786.93% |
| Café Serendipity Holdings, Inc. | 1.31 Million USD | -35552.663% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 543.26 Thousand USD | -86383.71% |
| HealthWarehouse.com, Inc. | 7.21 Million USD | -6412.204% |
| LIGAND PHARMACEUTICAL INC | 86.3 Million USD | -444.401% |
| MedGen, Inc. | 43.63 USD | -1076859858.744% |
| Omni Health, Inc. | 1.94 Million USD | -24098.066% |
| Oxford Investments Holdings Inc. | 1.01 Million USD | -46091.221% |
| Pineapple, Inc. | 10.61 Million USD | -4325.321% |
| ScripsAmerica, Inc. | 9.16 Million USD | -5025.168% |